The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib ResistanceAriel Ka-Man Chow, Roberta Wen-Chi Pang|PLoS ONE|2013Cited by 124
Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 InhibitorsOscar Hou In Chou, Jiandong Zhou, Raymond Chan et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 24